Related Experiment Video
Updated: May 29, 2026

Modeling Paracrine Noncanonical Wnt Signaling In Vitro
Published on: December 10, 2021
Wnt antagonists bind through a short peptide to the first β-propeller domain of LRP5/6
Eric Bourhis1, Weiru Wang, Christine Tam
1Department of Early Discovery Biochemistry, Genentech Research and Early Development, 1 DNA Way, South San Francisco, CA 94080, USA.
Abstract:
The Wnt pathway inhibitors DKK1 and sclerostin (SOST) are important therapeutic targets in diseases involving bone loss or damage. It has been appreciated that Wnt coreceptors LRP5/6 are also important, as human missense mutations that result in bone overgrowth (bone mineral density, or BMD, mutations) cluster to the E1 propeller domain of LRP5. Here, we report a crystal structure of LRP6 E1 bound to an antibody, revealing that the E1 domain is a peptide recognition module. Remarkably, the consensus E1 binding sequence is a close match to a conserved tripeptide motif present in all Wnt inhibitors that bind LRP5/6. We show that this motif is important for DKK1 and SOST binding to LRP6 and for inhibitory function, providing a detailed structural explanation for the effect of the BMD mutations.
Insights
Wnt pathway inhibitors like DKK1 and sclerostin (SOST) bind to LRP5/6 coreceptors. A newly discovered tripeptide motif on these inhibitors is crucial for binding and Wnt signaling inhibition, explaining bone density mutations.
Area of Science:
- Biochemistry
- Structural Biology
- Bone Biology
Background:
- Wnt pathway inhibitors, DKK1 and sclerostin (SOST), are key therapeutic targets for bone diseases.
- Wnt coreceptors LRP5/6 are critical, with mutations affecting bone mineral density (BMD).
Purpose of the Study:
- To elucidate the structural basis of Wnt inhibitor binding to LRP5/6.
- To understand the role of the LRP5/6 E1 domain in Wnt signaling modulation.
Main Methods:
- X-ray crystallography of LRP6 E1 domain bound to an antibody.
- Sequence analysis to identify conserved motifs in Wnt inhibitors.
- Functional assays to assess inhibitor binding and Wnt pathway activity.
Main Results:
- The LRP6 E1 domain functions as a peptide recognition module.
- A conserved tripeptide motif in DKK1 and SOST matches the LRP6 E1 binding sequence.
- This motif is essential for DKK1 and SOST binding to LRP6 and their inhibitory function.
Conclusions:
- The identified tripeptide motif provides a structural mechanism for Wnt inhibitor action.
- This finding explains the impact of bone overgrowth (BMD) mutations on LRP5/6.
- Offers insights for developing targeted therapies for bone disorders.
More Related Videos
Related Concept Videos
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Mechanism of Lamellipodia Formation
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
